Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-B3958-50 50 µg (0.5 mg/ml) $485 
CLEC2D / OCIL / LLT1 Antibody - Anti-CLEC2D antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 3.75 ug/ml.
CLEC2D / OCIL / LLT1 Antibody - Anti-CLEC2D antibody IHC of human placenta. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 3.75 ug/ml.
CLEC2D / OCIL / LLT1 Antibody - CLEC2D / OCIL / LLT1 antibody immunofluorescence analysis of paraformaldehyde fixed A431 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing cytoplasmic/membrane staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).
CLEC2D / OCIL / LLT1 Antibody - CLEC2D / OCIL / LLT1 antibody (0.3µg/ml) staining of U937 cell lysate (35µg protein in RIPA buffer). Detected by chemiluminescence.
CLEC2D / OCIL / LLT1 Antibody - CLEC2D / OCIL / LLT1 antibody flow cytometric analysis of paraformaldehyde fixed Jurkat cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.
CLEC2D / OCIL / LLT1 Antibody - Anti-CLEC2D antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 3.75 ug/ml.
CLEC2D / OCIL / LLT1 Antibody - Anti-CLEC2D antibody IHC of human placenta. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 3.75 ug/ml.
CLEC2D / OCIL / LLT1 Antibody - CLEC2D / OCIL / LLT1 antibody immunofluorescence analysis of paraformaldehyde fixed A431 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing cytoplasmic/membrane staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).
CLEC2D / OCIL / LLT1 Antibody - CLEC2D / OCIL / LLT1 antibody (0.3µg/ml) staining of U937 cell lysate (35µg protein in RIPA buffer). Detected by chemiluminescence.
CLEC2D / OCIL / LLT1 Antibody - CLEC2D / OCIL / LLT1 antibody flow cytometric analysis of paraformaldehyde fixed Jurkat cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.
1 of 5
2 of 5
3 of 5
4 of 5
5 of 5

IHC‑plus™ Polyclonal Goat anti‑Human CLEC2D / OCIL / LLT1 Antibody (aa122‑131, IHC, IF, WB) LS‑B3958

IHC‑plus™ Polyclonal Goat anti‑Human CLEC2D / OCIL / LLT1 Antibody (aa122‑131, IHC, IF, WB) LS‑B3958

Note: This antibody replaces LS-C109077
Antibody:
CLEC2D / OCIL / LLT1 Goat anti-Human Polyclonal (aa122-131) Antibody
Application:
IHC, IHC-P, IF, WB, Peptide-ELISA
Reactivity:
Human, Monkey, Horse
Format:
Unconjugated, Unmodified
Price
Catalog Number
$485
LS-B3958-50
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
CLEC2D / OCIL / LLT1 Goat anti-Human Polyclonal (aa122-131) Antibody
Application:
IHC, IHC-P, IF, WB, Peptide-ELISA
Reactivity:
Human, Monkey, Horse
Format:
Unconjugated, Unmodified

Specifications

Description
LLT1 antibody LS-B3958 is an unconjugated goat polyclonal antibody to LLT1 (CLEC2D / OCIL) (aa122-131) from human. It is reactive with human, horse and monkey. Validated for IF, IHC, Peptide-ELISA and WB. Tested on 20 paraffin-embedded human tissues.
Target
Human CLEC2D / OCIL / LLT1
Synonyms
CLEC2D | C-type lectin related f | CLAX | LLT-1 | LLT1 | OCIL | Osteoclast inhibitory lectin | Lectin-like NK cell receptor | Lectin-like transcript 1
Host
Goat
Reactivity
Human, Monkey, Horse (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Modifications
Unmodified
Immunogen
Peptide with sequence C-LLRYKGPSDH, from the Internal region of the protein sequence according to NP_037401.1NP_001004419.1NP_001184246.1.
Epitope
aa122-131
Specificity
Human CLEC2D.
Applications
  • IHC
  • IHC - Paraffin (3.75 µg/ml)
  • Immunofluorescence (10 µg/ml)
  • Western blot (0.3 - 1 µg/ml)
  • Peptide Enzyme-Linked Immunosorbent Assay (1:16000)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Usage
Immunohistochemistry: LS-B3958 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B3958 was determined to be 3.75 ug/ml.
Presentation
TBS, pH 7.3, 0.02% Sodium Azide, 0.5% BSA
Storage
Aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About CLEC2D / OCIL / LLT1
Q9UHP7 NM_013269 NP_037401.1

Validation

CLEC2D / OCIL / LLT1 Antibody - Anti-CLEC2D antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 3.75 ug/ml.
Anti-CLEC2D antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 3.75 ug/ml.
Anti-CLEC2D antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 3.75 ug/ml.

CLEC2D / OCIL / LLT1 Antibody - Anti-CLEC2D antibody IHC of human placenta. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 3.75 ug/ml.
Anti-CLEC2D antibody IHC of human placenta. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 3.75 ug/ml.
Anti-CLEC2D antibody IHC of human placenta. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 3.75 ug/ml.

LSBio Ratings

IHC-plus™ CLEC2D / OCIL / LLT1 Antibody (aa122-131) for IHC, IF/Immunofluorescence, WB/Western LS-B3958 has an LSBio Rating of
Laboratory Validation Score (4)

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 12/26/2024